BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32627515)

  • 1. Dysregulation of the immune system as a driver of the critical course of novel coronavirus disease 2019.
    Kosmaczewska A; Frydecka I
    Pol Arch Intern Med; 2020 Sep; 130(9):779-788. PubMed ID: 32627515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.
    Liu P; Hong Y; Yang B; Shrestha P; Sajjad N; Chen JL
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32961897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Management of Cytokine Storm in COVID-19.
    Rumende CM; Susanto EC; Sitorus TP
    Acta Med Indones; 2020 Jul; 52(3):306-313. PubMed ID: 33020343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
    Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
    Front Immunol; 2020; 11():1748. PubMed ID: 32849623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Science Underlying COVID-19: Implications for the Cardiovascular System.
    Liu PP; Blet A; Smyth D; Li H
    Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immune system and COVID-19: Friend or foe?
    Yazdanpanah F; Hamblin MR; Rezaei N
    Life Sci; 2020 Sep; 256():117900. PubMed ID: 32502542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible mechanisms responsible for acute coronary events in COVID-19.
    Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
    Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review).
    Cavalli E; Bramanti A; Ciurleo R; Tchorbanov AI; Giordano A; Fagone P; Belizna C; Bramanti P; Shoenfeld Y; Nicoletti F
    Int J Mol Med; 2020 Sep; 46(3):903-912. PubMed ID: 32588061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of the immune system to fight viruses highlighted by cytometry and T-cell receptor clonotype assessment: lessons taken before the coronavirus disease 2019 pandemic outbreak.
    Jaskuła E; Lange A
    Pol Arch Intern Med; 2020 Aug; 130(7-8):662-667. PubMed ID: 32449333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2-A Tough Opponent for the Immune System.
    Nasab MG; Saghazadeh A; Rezaei N
    Arch Med Res; 2020 Aug; 51(6):589-592. PubMed ID: 32532524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.
    Channappanavar R; Perlman S
    Semin Immunopathol; 2017 Jul; 39(5):529-539. PubMed ID: 28466096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
    Nowill AE; de Campos-Lima PO
    J Immunol; 2020 Nov; 205(10):2566-2575. PubMed ID: 32958687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection.
    Cavalli E; Petralia MC; Basile MS; Bramanti A; Bramanti P; Nicoletti F; Spandidos DA; Shoenfeld Y; Fagone P
    Int J Mol Med; 2020 Oct; 46(4):1266-1273. PubMed ID: 32945352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
    Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
    Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin.
    Alunno A; Carubbi F; Rodríguez-Carrio J
    RMD Open; 2020 May; 6(1):. PubMed ID: 32423970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs.
    Scala S; Pacelli R
    Front Immunol; 2020; 11():1201. PubMed ID: 32574268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine Storm in COVID19: A Neural Hypothesis.
    Ur A; Verma K
    ACS Chem Neurosci; 2020 Jul; 11(13):1868-1870. PubMed ID: 32605374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
    Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
    Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure.
    Thierry AR; Roch B
    Clin Sci (Lond); 2020 Jun; 134(12):1295-1300. PubMed ID: 32543703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.